- Home
- CRMD vs QD Comparison
CRMD vs QD Comparison
Compare CRMD & QD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | QD |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 943.9M | 807.5M |
| IPO Year | 2010 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CRMD | QD |
|---|---|---|
| Price | $12.05 | $3.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.43 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 321.1K |
| Earning Date | 11-12-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2364.38 |
| EPS | ★ 2.25 | 0.67 |
| Revenue | ★ $214,303,672.00 | $12,647,260.00 |
| Revenue This Year | $627.89 | N/A |
| Revenue Next Year | $40.95 | N/A |
| P/E Ratio | ★ $5.41 | $5.75 |
| Revenue Growth | ★ 1647.67 | N/A |
| 52 Week Low | $5.60 | $2.04 |
| 52 Week High | $17.43 | $5.08 |
Technical Indicators
Market Signals| Indicator | CRMD | QD |
|---|---|---|
| Relative Strength Index (RSI) | 63.43 | 33.60 |
| Support Level | $11.78 | $3.64 |
| Resistance Level | $12.51 | $3.93 |
| Average True Range (ATR) | 0.51 | 0.19 |
| MACD | 0.13 | -0.08 |
| Stochastic Oscillator | 85.18 | 13.60 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.